Literature DB >> 2958141

Sensitization through carcinogen-induced Langerhans cell-deficient skin activates specific long-lived suppressor cells for both cellular and humoral immunity.

G M Halliday1, H K Muller.   

Abstract

Application of 2,4-dinitrofluorobenzene (DNFB) to BALB/c mouse skin depleted of epidermal Langerhans cells (LC) by the chemical carcinogen 7,12-dimethylbenz[a]anthracene (DMBA) activated cells which suppress both contact sensitivity and antibody production when transferred into naive host mice. Tolerance was induced by a concentration of DNFB optimal for inducing contact sensitivity in solvent-treated control mice. The cellular and humoral responses of hosts to a second antigen, 2,4,6-trinitrochlorobenzene (TNCB), were unaffected by these suppressor cells, demonstrating specificity for DNFB. Suppressor cells for cellular and humoral immunity could still be demonstrated 6 months following activation, by which time some mice had died, presumably of old age. The dose responses to sensitizer for generation of cells which suppressed contact sensitivity and antibody production differed, indicating that separate populations of suppressor cells probably inhibit these responses. Hence, during cutaneous chemical carcinogenesis, depletion of LC may allow activation of specific long-lived suppressor cells capable of inhibiting cellular or humoral antitumor immune responses.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2958141     DOI: 10.1016/0008-8749(87)90305-4

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  10 in total

1.  Carcinogen-modified dendritic cells induce immunosuppression by incomplete T-cell activation resulting from impaired antigen uptake and reduced CD86 expression.

Authors:  G M Woods; K V Doherty; R C Malley; M J Rist; H K Muller
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

Review 2.  Acquired and innate immunity to polyaromatic hydrocarbons.

Authors:  Nabiha Yusuf; Laura Timares; Megan D Seibert; Hui Xu; Craig A Elmets
Journal:  Toxicol Appl Pharmacol       Date:  2006-12-19       Impact factor: 4.219

3.  Presentation of antigen to suppressor cells by a dimethylbenz (a) anthracene-resistant, Ia-positive, Thy-1-negative, I-J-restricted epidermal cell.

Authors:  G M Halliday; R C Wood; H K Muller
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

4.  Effects of gliotoxin on Langerhans' cell function: contact hypersensitivity responses and skin graft survival.

Authors:  P C McMinn; G M Halliday; H K Muller
Journal:  Immunology       Date:  1990-09       Impact factor: 7.397

5.  Chemical carcinogens and antigens induce immune suppression via Langerhans' cell depletion.

Authors:  G M Woods; M Qu; S J Ragg; H K Muller
Journal:  Immunology       Date:  1996-05       Impact factor: 7.397

6.  A role for prostaglandins in the suppression of cutaneous cellular immunity and tumour development in benzo(a)pyrene- but not dimethylbenz(a)anthracene-treated mice.

Authors:  J Andrews; G M Halliday; H K Muller
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

7.  Control of Langerhans' cell density by a skin tumour-derived cytokine.

Authors:  G M Halliday; A D Lucas; R S Barnetson
Journal:  Immunology       Date:  1992-09       Impact factor: 7.397

8.  Retinoic acid protects Langerhans' cells from the effects of the tumour promotor 12-O-tetradecanoylphorbol 13-acetate.

Authors:  G M Halliday; J L Dickinson; H K Muller
Journal:  Immunology       Date:  1989-07       Impact factor: 7.397

9.  Langerhans cell migration patterns from sheep skin following topical application of carcinogens.

Authors:  S J Ragg; G W Dandie; G M Woods; P J O'Connell; H K Muller
Journal:  Int J Exp Pathol       Date:  1994-02       Impact factor: 1.925

Review 10.  The relevance of the vitamin D endocrine system (VDES) for tumorigenesis, prevention, and treatment of non-melanoma skin cancer (NMSC): Present concepts and future perspectives.

Authors:  Jörg Reichrath; Sandra Reichrath
Journal:  Dermatoendocrinol       Date:  2013-01-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.